Bafna Pharmaceuticals Ltd. - Research Center
532989 BAFNAPH Group (T) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
82.63 |
38.89 |
35.44 |
49.70 |
31.90 |
Operating profit |
10.30 |
4.20 |
2.31 |
9.18 |
3.89 |
Interest |
1.04 |
0.76 |
0.58 |
0.22 |
0.04 |
Gross profit |
11.29 |
5.38 |
3.49 |
9.31 |
4.25 |
EPS (Rs) |
3.73 |
1.26 |
0.29 |
1.89 |
0.97 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
2.03 |
1.94 |
1.76 |
0.35 |
0.40 |
Stock adjustment |
-1.28 |
-2.22 |
1.00 |
-2.78 |
0.42 |
Raw material |
39.23 |
26.46 |
21.02 |
32.04 |
21.20 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
9.12 |
7.24 |
7.35 |
7.16 |
4.81 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
25.26 |
3.21 |
3.76 |
4.10 |
1.58 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
2.45 |
2.41 |
2.61 |
2.88 |
1.96 |
Taxation |
- |
- |
- |
- |
- |
Net profit / loss |
8.83 |
2.97 |
0.69 |
4.46 |
2.29 |
Extra ordinary item |
- |
- |
-0.19 |
-1.97 |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
23.66 |
23.66 |
23.66 |
23.66 |
23.66 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
12.46 |
10.80 |
6.52 |
18.47 |
12.18 |
GPM (%) |
13.33 |
13.18 |
9.38 |
18.61 |
13.16 |
NPM (%) |
10.44 |
7.28 |
1.85 |
8.92 |
7.09 |